¹Hend R. A. Awad,²Naeima A. S. AL-Agori,¹Manal F Yaya,³Fatma I. Zoubi,³Rahma Y. Alramly,³Salha A Khaled,³Noor Alhuda F AbdoAllah,^1,4Abeer H. A. Amer

¹Faculty of Medicine, University of Benghazi, Benghazi, Libya

²Faculty of Dentistry, University of Benghazi, Benghazi, Libya

³Faculty of Biomedical Sciences, University of Benghazi, Benghazi, Libya

⁴Faculty of Applied Medical Science, Libyan International Medical University, Benghazi, Libya

Urinary bladder cancer is the main reason for morbidity and mortality throughout the world. Urothelial carcinoma is a common primary tumor of urinary bladder (90%). To investigate the epidemiological and histopathological aspects in Libyan patients suffering from urinary bladder cancer, we performed a study on 39 bladder cancer biopsies from transurethral resection of bladder tumor (TURBT) and cystoscopic samples obtained from Oncology Department- Al Hawari Hospital, over the period of (2021- May 2022), Tiba Medical Laboratory (2021- July 2022), and Alnoon Medical laboratory (2019- January 2022) at Benghazi, Libya. Of the 39 cases, 34 (87.2%) were diagnosed in men, and 5 (12.8%) were found in women, the men/ women ratio being of 6.8/1. The highest incidence of bladder tumors was recorded in individuals aged between 61 and 80 years old. In this age group, there were admitted 24 patients with bladder cancer, representing 61.5%. The most common pathological types of urinary bladder carcinoma found was Invasive Urothelial Carcinoma TCC (48.72%) followed by noninvasive Urothelial Carcinoma TCC (46.15%), and Squamous Cell Carcinoma SCC in (5.13%). A case of SCC on top of Schistosomiasis was also seen. Grade III was found in 51.2% of our patients and 43.5% of them had stage II. This study has highlighted upon the importance of histopathological study in evaluating urinary bladder cancer. Cystoscopic studies and biopsies help in early detection of bladder neoplasms and they form the mainstay of the diagnosis and follow up. The objects of this work were to assess epidemiological features of the bladder cancer in Benghazi - Libya with regard to frequency, age and sex distribution. Furthermore, to describe the Histopathological features of the urinary bladder cancer, particularly Transitional Cell Carcinoma (TCC) in urinary bladder biopsies.

Bladder Cancer, Transitional Cell Carcinoma, Histopathology.

1) American Cancer Society. (2016). Cancer Facts & Figures 2016. American Cancer Society.

2) Atallah A. Shaaban, Saad A. Orkubi, Mohammad T. Said, Boshra Yousef, Mohammed S. Abomelha. (1997). SQUAMOUS CELL CARCINOMA OF THE URINARY BLADDER. Annals of Saudi Medicine,17.

3) Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D. and Bray, F. (2015). Cancer Incidence and Mortality Worldwide: Sources, Methods and Major Patterns in GLOBOCAN 2012. International Journal of Cancer, 136.

4) Goldblum John R., Lamps Laura W. McKenney ,Jesse K., MyersJeffrey L. . (2018). Rosai and Ackerman’s Surgical Pathology (11 ed.). Philadelphia, PA: ELSEVIER.

5) Golka K, Wiese A, Assennato G, Bolt HM. (2004). Occupational exposure and urological cancer. World J Urol, 21, 391.

6) Honoré Jean Gabriel Berthé, Dramane Cissé, Moussa Salifou Diallo, Amadou Kassogué. Alkadri Diarra, Mamadou Tidiani Coulibaly, Mamadou Lamine Diakité,Modibo Coulibaly, Mory Koné. (2021). Bladder Cancer: Epidemiological, Clinical and Histopathological Aspects at the University Hospital Point G, Mali. Open Journal of Urology, 343-350, 343- 350.

7) Kumar U Mahesh & Yelikar B.R. (2012). Spectrum of Lesions in Cystoscopic Bladder Biopsies -A Histopathological Study.Al Ameen J Med S ci ,5 (2):1 3 2 -1 3 6.

8) Letasiova S., Medvedova A. , Sovcikova A. et al. (2012). Bladder cancer, a review of the environmental risk factors. Environmental Health, 11.

9) Matalka I, Bani-Hani K, Shotar A, Bani Hani O, BaniHani I. (2008). Transitional cell carcinoma of the urinary bladder: a clinicopathological study. Singapore Med J. Oct;49(10):7.

10) Nagy AA, Darweish H, Hamdey HM, Elkalla R, Abdu-allah H, et al. (2018) Factors Affecting Survival in Egyptian Patients Suffering from Urinary Bladder Cancer: A Multicenter Retrospective Study. J Cancer Sci Ther 10: 031- 035.

11) Otto W, May M, Fritsche HM, et al. (2012). Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder. Gend Med, 9, 481-489.

12) Parkin DM, Bray F, Ferlay J, Pisani P. (2002). Global cancer statistics. CA Cancer J Clin, 55, 108.

13) Paudel Deliya , Regmi Himanshu , Bajracharya Uspal , Shrestha Guna K. (2021). Spectrum and Presentation of Urinary Bladder Growth: a Single-Center Retrospective Study. Nepalese Medical Journal, 4,485-488.

14) Ștefanescu M.L., Tomescu P.I., Fortofoiu M.C., Stoica L.E., Badea Oana, Mogoanta L., Ionovic Nina. (2018). Urinary Bladder Tumors Clinical and Statistical Retrospective Study.Current Health Sciences Journal,44:1.

15) Worst Thomas S. , Reiner Verena , Gabriel Ute ,Weiß Christel , Erben Philipp . (2014). IL1RN and KRT13 Expression in Bladder Cancer: Association with Pathologic Characteristics and Smoking Status. Advances in Urology.

VOLUME 06 ISSUE 03 MARCH 2023

There is an Open Access article, distributed under the term of the Creative Commons Attribution – Non Commercial 4.0 International (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/), which permits remixing, adapting and building upon the work for non-commercial use, provided the original work is properly cited.